News
MAIA Biotechnology, Inc. (NYSE:MAIA), a clinical-stage biopharmaceutical company, has announced a private placement agreement ...
Princeton University awarded honorary degrees to the following recipients during the 2025 Commencement ceremony on Tuesday, ...
SAN FRANCISCO, May 27, 2025 (GLOBE NEWSWIRE) -- 23andMe Holding Co. (“23andMe” or the “Company”) (OTC: MEHCQ), a leading ...
Rajiv Gandhi Centre for Biotechnology (RGCB), Thiruvananthapuram, has invited applications for admission to the PhD programme, starting in August 2025, in various domains of disease biology, ...
Researchers have developed a machine learning model called DreaMS, which significantly accelerates the analysis of previously unknown molecules. The study is published in Nature Biotechnology.
Inc. , (the "Company" or "MindMed"), a late-stage clinical biopharmaceutical company developing novel product candidates to treat brain health disorders, today announced the appointment of Brandi L.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results